AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28209359 — intervention group
Group type: EXPERIMENTAL
Intervention: 60mg Fimasartan + 12.5mg HCTZ
Number of subjects: 272
Study 28209359 — intervention group
Group type: EXPERIMENTAL
Intervention: 120mg Fimasartan + 12.5mg HCTZ
Number of subjects: 272
Study 28209359 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall treatment
Number of subjects: 272
Study 28209359 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse reactions
Number of subjects: 272
Study 25443384 — intervention group
Group type: EXPERIMENTAL
Intervention: TXA irrigation with normal saline (1 mg/mL)
Number of subjects: 56
Study 25443384 — intervention group
Group type: COMPARATOR
Intervention: Normal saline for irrigation
Number of subjects: 56
Study 23911216 — intervention group
Group type: EXPERIMENTAL
Intervention: One extra egg per day
Number of subjects: 97
Study 23911216 — intervention group
Group type: EXPERIMENTAL
Intervention: Buttermilk drink containing one egg yolk
Number of subjects: 97
Study 23911216 — intervention group
Group type: COMPARATOR
Intervention: Control group (regular egg consumption)
Number of subjects: 97
Study 21527854 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg/d
Number of subjects: 64
Study 21527854 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 18854397 — intervention group
Group type: EXPERIMENTAL
Intervention: rhTNF-alpha (700 ng . m(‐2) . h(‐1))
Number of subjects: 8
Study 18854397 — intervention group
Group type: COMPARATOR
Intervention: 20% human albumin (control)
Number of subjects: 8
Study 17089085 — intervention group
Group type: EXPERIMENTAL
Intervention: Omacor 1 g/day
Number of subjects: 38
Study 17089085 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 38
Study 15116862 — intervention group
Group type: EXPERIMENTAL
Intervention: Transtelephonic event recorder (TER)
Number of subjects: 310
Study 15116862 — intervention group
Group type: COMPARATOR
Intervention: 24-hour Holter monitoring
Number of subjects: 310
Study 15116862 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost-effectiveness of TER
Number of subjects: 310
Study 15116862 — intervention group
Group type: EXPERIMENTAL
Intervention: Time to diagnosis with TER
Number of subjects: 310
Study 15116862 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost-effectiveness analysis
Number of subjects: 310
Study 11126938 — intervention group
Group type: EXPERIMENTAL
Intervention: Recognition judgments with instructions conforming to those reported by Jacoby (1991)
Number of subjects: 0
Study 11126938 — intervention group
Group type: EXPERIMENTAL
Intervention: Fame judgments in the process dissociation procedure
Number of subjects: 0
Study 8996011 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal oxygen therapy
Number of subjects: 20
Study 8370131 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin 2 mg administered at 1600 and 2000 h
Number of subjects: 7
Study 8370131 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 8370131 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin
Number of subjects: 7
Study 3529744 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasmaexchange (group A)
Number of subjects: 44
Study 3529744 — intervention group
Group type: COMPARATOR
Intervention: Drug therapy only (group B)
Number of subjects: 44
Study 3529744 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasmaexchange therapy
Number of subjects: 44
Study 31678222 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted arm therapy and hand functional electrical stimulation (RAT+FES)
Number of subjects: 40
Study 31678222 — intervention group
Group type: COMPARATOR
Intervention: Intensive conventional therapy
Number of subjects: 40
Study 28872259 — intervention group
Group type: EXPERIMENTAL
Intervention: Precipitating factors identified at admission (CV, non-CV, unknown)
Number of subjects: 1668
Study 28872259 — intervention group
Group type: EXPERIMENTAL
Intervention: Precipitating factors identified at admission (arrhythmia, respiratory infection, other non-CV factors)
Number of subjects: 1668
Study 28872259 — intervention group
Group type: EXPERIMENTAL
Intervention: Precipitating factors (CV, non-CV, unknown)
Number of subjects: 1668
Study 26796630 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral Cochlear Implantation (BCI)
Number of subjects: 38
Study 26796630 — intervention group
Group type: COMPARATOR
Intervention: Unilateral Cochlear Implantation (UCI)
Number of subjects: 38
Study 24291283 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical Aortic Valve Replacement (SAVR)
Number of subjects: 657
Study 24291283 — intervention group
Group type: COMPARATOR
Intervention: Transfemoral Transcatheter Aortic Valve Replacement (TF-TAVR)
Number of subjects: 657
Study 24291283 — intervention group
Group type: COMPARATOR
Intervention: Transapical Transcatheter Aortic Valve Replacement (TA-TAVR)
Number of subjects: 657
Study 24291283 — intervention group
Group type: EXPERIMENTAL
Intervention: Major bleeding complications (BC)
Number of subjects: 657
Study 22894640 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids (640 mg t.i.d during chemotherapy with paclitaxel and one month after)
Number of subjects: 57
Study 22894640 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study 22894640 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids
Number of subjects: 57
Study 20865998 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-delivered intervention
Number of subjects: 0
Study 18540800 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducation workshop
Number of subjects: 50
Study 18540800 — intervention group
Group type: COMPARATOR
Intervention: Waitlist (Control)
Number of subjects: 50
Study 16371893 — intervention group
Group type: EXPERIMENTAL
Intervention: Spine clinic intervention (medical examination, information, reassurance, encouragement to engage in physical activity)
Number of subjects: 457
Study 16371893 — intervention group
Group type: EXPERIMENTAL
Intervention: Spine clinic intervention
Number of subjects: 457
Study 16371893 — intervention group
Group type: COMPARATOR
Intervention: Usual primary healthcare treatment
Number of subjects: 457
Study 12208703 — intervention group
Group type: EXPERIMENTAL
Intervention: Argon laser peripheral iridoplasty (ALPI)
Number of subjects: 64
Study 12208703 — intervention group
Group type: COMPARATOR
Intervention: Conventional systemic medical therapy
Number of subjects: 64
Study 10342702 — intervention group
Group type: EXPERIMENTAL
Intervention: Two doses of measles vaccine at 6 and 9 months
Number of subjects: 2181
Study 10342702 — intervention group
Group type: COMPARATOR
Intervention: One dose of inactivated polio vaccine (IPV) at 6 months and measles vaccine at 9 months
Number of subjects: 2181
Study 8676932 — intervention group
Group type: COMPARATOR
Intervention: Rifabutin (300 mg daily)
Number of subjects: 693
Study 8676932 — intervention group
Group type: COMPARATOR
Intervention: Azithromycin (1200 mg weekly)
Number of subjects: 693
Study 8676932 — intervention group
Group type: COMPARATOR
Intervention: Both drugs (Rifabutin and Azithromycin)
Number of subjects: 693
Study 8676932 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 693
Study 8676932 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 693
Study 1886824 — intervention group
Group type: EXPERIMENTAL
Intervention: Scotchbond (3M Dental Products, St. Paul, MN) - etched
Number of subjects: 40
Study 1886824 — intervention group
Group type: COMPARATOR
Intervention: Scotchbond (3M Dental Products, St. Paul, MN) - unetched
Number of subjects: 40
Study 1886824 — intervention group
Group type: EXPERIMENTAL
Intervention: Scotchbond 2 (3M Dental Products, St. Paul, MN) - etched
Number of subjects: 40
Study 1886824 — intervention group
Group type: COMPARATOR
Intervention: Scotchbond 2 (3M Dental Products, St. Paul, MN) - unetched
Number of subjects: 40
Study 1886824 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluma (Bayer Dental, Leverkusen, Federal Republic of Germany) - etched
Number of subjects: 40
Study 1886824 — intervention group
Group type: COMPARATOR
Intervention: Gluma (Bayer Dental, Leverkusen, Federal Republic of Germany) - unetched
Number of subjects: 40
Study 1886824 — intervention group
Group type: EXPERIMENTAL
Intervention: Bondlite (Kerr Manufacturing Co., Romulus, MI) - etched
Number of subjects: 40
Study 1886824 — intervention group
Group type: COMPARATOR
Intervention: Bondlite (Kerr Manufacturing Co., Romulus, MI) - unetched
Number of subjects: 40
Study 6175137 — intervention group
Group type: EXPERIMENTAL
Intervention: Active transfer factor (TF)
Number of subjects: 16
Study 6175137 — intervention group
Group type: COMPARATOR
Intervention: Heat-inactivated transfer factor (placebo)
Number of subjects: 16
Study 30531420 — intervention group
Group type: EXPERIMENTAL
Intervention: PASCAL PRP
Number of subjects: 0
Study 30531420 — intervention group
Group type: COMPARATOR
Intervention: Conventional laser PRP
Number of subjects: 0
Study 30531420 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (PASCAL and Conventional)
Number of subjects: 0
Study 31808921 — intervention group
Group type: EXPERIMENTAL
Intervention: True Acupuncture (TA)
Number of subjects: 339
Study 31808921 — intervention group
Group type: EXPERIMENTAL
Intervention: Sham Acupuncture (SA)
Number of subjects: 339
Study 31808921 — intervention group
Group type: COMPARATOR
Intervention: Standard Care Control (SCC)
Number of subjects: 339
Study 28186425 — intervention group
Group type: EXPERIMENTAL
Intervention: IM tramadol/propofol fast (GIMF)
Number of subjects: 24
Study 28186425 — intervention group
Group type: COMPARATOR
Intervention: IM tramadol/propofol slow (GIMS)
Number of subjects: 24
Study 28186425 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral tramadol/propofol fast (GOF)
Number of subjects: 24
Study 28186425 — intervention group
Group type: COMPARATOR
Intervention: Oral tramadol/propofol slow (GOS)
Number of subjects: 24
Study 26122425 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,470-nm endovenous laser ablation (EVLA)
Number of subjects: 120
Study 26122425 — intervention group
Group type: COMPARATOR
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 120
Study 23557881 — intervention group
Group type: EXPERIMENTAL
Intervention: High-normal proficiency group
Number of subjects: 30
Study 23557881 — intervention group
Group type: COMPARATOR
Intervention: Low-normal proficiency group
Number of subjects: 30
Study 22009806 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative antibiotic prophylaxis administered before TUL
Number of subjects: 114
Study 22009806 — intervention group
Group type: COMPARATOR
Intervention: TUL without antibiotic prophylaxis
Number of subjects: 114
Study 19571807 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP2C9 and VKORC1 genotype-guided dosing
Number of subjects: 0
Study 19571807 — intervention group
Group type: COMPARATOR
Intervention: Control (standard dosing without genotype guidance)
Number of subjects: 0
Study 15878727 — intervention group
Group type: EXPERIMENTAL
Intervention: Focal basal ganglia lesions
Number of subjects: 0
Study 15878727 — intervention group
Group type: COMPARATOR
Intervention: Control group (patients with focal lesions of other brain structures)
Number of subjects: 0
Study 12209278 — intervention group
Group type: COMPARATOR
Intervention: Labetalol (n=30)
Number of subjects: 60
Study 12209278 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine (n=30)
Number of subjects: 60
Study 12209278 — intervention group
Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 60
Study 10509499 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary, home-based intervention (home visit by a cardiac nurse 7-14 days after discharge)
Number of subjects: 200
Study 10509499 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary, home-based intervention
Number of subjects: 200
Study 10509499 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 200
Study 8733499 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulised acetylcysteine
Number of subjects: 10
Study 8733499 — intervention group
Group type: COMPARATOR
Intervention: Nebulised normal saline
Number of subjects: 10
Study 1926232 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy (surgery)
Number of subjects: 410
Study 1926232 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy (acetylsalicylic acid and dipyridamole)
Number of subjects: 410
Study 6861867 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotalol 100 mg intravenously
Number of subjects: 6
Study 6861867 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotalol 400 mg orally
Number of subjects: 6
Study 30879998 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.37 μg of Alt a 1
Number of subjects: 0
Study 30879998 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 μg of Alt a 1
Number of subjects: 0
Study 30879998 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 28739973 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated Linoleic Acid (cLA) coadministered with 15NO2‐
Number of subjects: 0
Study 28739973 — intervention group
Group type: COMPARATOR
Intervention: 15NO2‐
Number of subjects: 0
Study 28739973 — intervention group
Group type: COMPARATOR
Intervention: 15NO3‐ and 15NO2‐
Number of subjects: 0
Study 26111165 — intervention group
Group type: EXPERIMENTAL
Intervention: Hatha yoga intervention (12 weeks)
Number of subjects: 173
Study 26111165 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 173
Study 24780066 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose glucose (0.1 g/kg/h for 1 h followed by 0.05 g/kg/h for 1 h)
Number of subjects: 34
Study 24780066 — intervention group
Group type: COMPARATOR
Intervention: No glucose (0G group)
Number of subjects: 34
Study 24780066 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose glucose (LG group)
Number of subjects: 34
Study 23062390 — intervention group
Group type: EXPERIMENTAL
Intervention: Preseasonal grass pollen immunotherapy
Number of subjects: 0
Study 23062390 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 19453867 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral health education program (4-month duration)
Number of subjects: 247
Study 19453867 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 247
Study 17949398 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine (CQ)
Number of subjects: 653
Study 17949398 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulphadoxine-pyrimethamine (SP)
Number of subjects: 653
Study 17949398 — intervention group
Group type: COMPARATOR
Intervention: Both CQ and SP
Number of subjects: 653
Study 15898864 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavior therapy for insomnia during discontinuation
Number of subjects: 52
Study 15898864 — intervention group
Group type: COMPARATOR
Intervention: No cognitive-behavior therapy for insomnia during discontinuation
Number of subjects: 52
Study 12471781 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% hyperbaric bupivacaine with clonidine 2 micrograms.kg‐1
Number of subjects: 45
Study 12471781 — intervention group
Group type: COMPARATOR
Intervention: 0.5% hyperbaric bupivacaine
Number of subjects: 45
Study 9819068 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisol 40 mg/d
Number of subjects: 47
Study 9819068 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisol 160 mg/d
Number of subjects: 47
Study 9819068 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 7543407 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-hydroxy-L-tryptophan (L-5-HTP) plus carbidopa
Number of subjects: 6
Study 7543407 — intervention group
Group type: EXPERIMENTAL
Intervention: L-5-HTP
Number of subjects: 6
Study 2694344 — intervention group
Group type: EXPERIMENTAL
Intervention: Furazolidone (5 mg/kg/day for 5 days)
Number of subjects: 78
Study 2694344 — intervention group
Group type: COMPARATOR
Intervention: Ampicillin (100 mg/kg/day for 5 days)
Number of subjects: 78
Study 331465 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac sodium
Number of subjects: 6
Study 331465 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen
Number of subjects: 6
Study 331465 — intervention group
Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 6
Study 30724351 — intervention group
Group type: EXPERIMENTAL
Intervention: Hurley staging in the axillae
Number of subjects: 24
Study 30724351 — intervention group
Group type: EXPERIMENTAL
Intervention: Hurley staging in the gluteal region
Number of subjects: 24
Study 30724351 — intervention group
Group type: EXPERIMENTAL
Intervention: Hurley staging in the groin
Number of subjects: 24
Study 30724351 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician's Global Assessment
Number of subjects: 24
Study 30724351 — intervention group
Group type: EXPERIMENTAL
Intervention: Refined Hurley staging
Number of subjects: 24
Study 30724351 — intervention group
Group type: EXPERIMENTAL
Intervention: International HS Severity Scoring System
Number of subjects: 24
Study 29186247 — intervention group
Group type: EXPERIMENTAL
Intervention: OFI-ALA-PDT (optical intra-tissue fiber irradiation)
Number of subjects: 25
Study 29186247 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional ALA-PDT
Number of subjects: 25
Study 29186247 — intervention group
Group type: EXPERIMENTAL
Intervention: OFI (optical fiber irradiation)
Number of subjects: 25
Study 29186247 — intervention group
Group type: COMPARATOR
Intervention: Blank control group (no treatment)
Number of subjects: 25
Study 26681020 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg clopidogrel (test preparation)
Number of subjects: 32
Study 26681020 — intervention group
Group type: COMPARATOR
Intervention: 75 mg clopidogrel (reference preparation)
Number of subjects: 32
Study 26681020 — intervention group
Group type: EXPERIMENTAL
Intervention: Relative bioavailability of the test preparation
Number of subjects: 32
Study 23059649 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation of 4000 IU/day
Number of subjects: 44
Study 23059649 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation of 7000 IU/day
Number of subjects: 44
Study 23059649 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline serum 25D <50.0 nmol/L in 50% of subjects
Number of subjects: 44
Study 22136021 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture at Jiaji (EX-B 2), Shenshu (BL 23), Qihaishu (BL 24), Guanyuanshu (BL 26), Dachangshu (BL 25), Yangtlingquan (GB 34) once a day
Number of subjects: 85
Study 22136021 — intervention group
Group type: COMPARATOR
Intervention: Oral administration of Fugui Gutong capsule (3 times a day, 4 capsules each time) and 0.3 g ibuprofen (once a day)
Number of subjects: 85
Study 19593890 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose adenosine infusion
Number of subjects: 11
Study 19593890 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 11
Study 15899453 — intervention group
Group type: EXPERIMENTAL
Intervention: Cataract surgery with anterior vitrectomy
Number of subjects: 66
Study 15899453 — intervention group
Group type: COMPARATOR
Intervention: Cataract surgery without anterior vitrectomy
Number of subjects: 66
Study 15899453 — intervention group
Group type: EXPERIMENTAL
Intervention: Cataract surgery for after-cataract
Number of subjects: 66
Study 15899453 — intervention group
Group type: EXPERIMENTAL
Intervention: Cataract surgery with AcrySof SA30AL IOL
Number of subjects: 66
Study 12214948 — intervention group
Group type: EXPERIMENTAL
Intervention: Colgate Platinum
Number of subjects: 24
Study 12214948 — intervention group
Group type: EXPERIMENTAL
Intervention: Starbrite
Number of subjects: 24
Study 9456291 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine capsules (10 mg, two administrations 6 hours apart)
Number of subjects: 21
Study 9456291 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine-retard (20 mg tablets, single administration)
Number of subjects: 21
Study 8546978 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical handbook for continence care
Number of subjects: 124
Study 8546978 — intervention group
Group type: COMPARATOR
Intervention: Control group (no handbook)
Number of subjects: 124
Study 2576717 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium 'priming' group (10 micrograms.kg‐1 followed by 100 micrograms.kg‐1 4 min later)
Number of subjects: 340
Study 2576717 — intervention group
Group type: COMPARATOR
Intervention: Vecuronium 'control' group (100 micrograms.kg‐1)
Number of subjects: 340
Study 2576717 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium 'high dose' group (250 micrograms.kg‐1)
Number of subjects: 340
Study 2576717 — intervention group
Group type: EXPERIMENTAL
Intervention: Succinylcholine group (1 mg.kg‐1)
Number of subjects: 340
Study 16041 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mg triazolam
Number of subjects: 41
Study 16041 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg flurazepam
Number of subjects: 41
Study 16041 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 28405814 — intervention group
Group type: EXPERIMENTAL
Intervention: Virgin coconut oil (VCO)
Number of subjects: 15
Study 28405814 — intervention group
Group type: COMPARATOR
Intervention: Control (extra-virgin olive oil)
Number of subjects: 15
Study 27633643 — intervention group
Group type: COMPARATOR
Intervention: Enhanced Usual Care (EUC): a manualised consultation with a child and adolescent psychiatrist and individualised treatment plan
Number of subjects: 120
Study 27633643 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based Acceptance and Commitment Therapy (ACT) plus Enhanced Usual Care (EUC)
Number of subjects: 120
Study 24739659 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive and multidisciplinary program conducted in a rehabilitation center
Number of subjects: 180
Study 24739659 — intervention group
Group type: EXPERIMENTAL
Intervention: Less intensive outpatient program conducted by a private physiotherapist
Number of subjects: 180
Study 24739659 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed strategy combining outpatient program with a multidisciplinary intervention
Number of subjects: 180
Study 24739659 — intervention group
Group type: COMPARATOR
Intervention: Mixed strategy
Number of subjects: 180
Study 24739659 — intervention group
Group type: COMPARATOR
Intervention: Intensive and multidisciplinary program
Number of subjects: 180
Study 24739659 — intervention group
Group type: COMPARATOR
Intervention: Less intensive outpatient program
Number of subjects: 180
Study 22105505 — intervention group
Group type: EXPERIMENTAL
Intervention: Heidelberg retinal tomography
Number of subjects: 30